The RDC.DE stock plunged -14.38% intraday to €34.88 on XETRA on 19 Mar 2026, making Redcare Pharmacy one of today’s top losers. Volume reached 176,480.00 shares, nearly double the average, as traders reacted to continued profit concerns and sector pressure in Healthcare. We review what drove the move, the technical support to watch, and how our models and proprietary Meyka grade frame near-term risk and longer-term upside for Redcare Pharmacy N.V.
Why RDC.DE stock plunged intraday
RDC.DE stock opened at €37.10 and hit a day low of €34.82 as selling accelerated. The drop follows weak sentiment across retail pharmacy names and headlines flagging five-year lows in Redcare shares. Market reports linked today’s decline to larger European sell-offs and positioning into the earnings season source. The intraday move shows rapid risk aversion in the stock rather than a single company-only development.
Fundamentals and valuation pressure on Redcare Pharmacy (RDC.DE)
Redcare Pharmacy N.V. (RDC.DE) reports EPS -1.87 and a trailing PE of -20.12, reflecting persistent losses. Price to sales is 0.26 and price to book is 1.65, while cash per share is €10.12. The company has €765,239,969.00 market cap and tangible book value per share €4.26. These metrics help explain why downside moves produce outsized percentage declines: the stock remains priced for recovery, not perfection.
Technical picture and key intraday levels for RDC.DE stock
Technicals show oversold conditions: RSI 20.92 and Williams %R at -99.92. Bollinger lower band sits near €30.03, and the 50-day average is €59.38. Traders should watch immediate support at €30.00 and resistance near today’s open €37.10 and the 50-day at €59.38. High intraday volume and an ADX of 44.28 point to a strong down trend that could persist until clear buying interest returns.
Meyka AI rates RDC.DE with a score out of 100 and model forecasts
Meyka AI rates RDC.DE with a score out of 100. Meyka AI assigns 71.40 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a monthly level of €28.50 (-18.29% vs €34.88 current), a quarterly level of €26.28 (-24.66%), and a yearly projection of €94.27 (+170.36%). Forecasts are model-based projections and not guarantees. Use the model outputs alongside fundamentals and news flow.
Risks and catalysts to watch for RDC.DE trading on XETRA
Key risks: negative operating margins, interest coverage -1.41, net debt to EBITDA 4.93, and a recent D+ company rating flagged by some providers, which signals weak near-term fundamentals. Catalysts: the next earnings date on 06 May 2026, potential margin improvement from cost measures, and sector momentum if Healthcare names rebound. Monitor official company updates and coverage from major outlets for event-driven moves source.
Intraday trading strategy for top losers like RDC.DE stock
As a top loser, RDC.DE stock requires strict risk controls. Watch liquidity (volume 176,480.00) and set triggers: consider step-in only on sustained volume above average and a close above €37.50. Short-term traders should size positions conservatively and use stop-losses near €28.00. Longer-term investors should compare the stock’s valuation with recovery scenarios and follow Meyka AI model updates on the stock page: Meyka RDC.DE page.
Final Thoughts
RDC.DE stock’s -14.38% intraday drop to €34.88 on XETRA highlights near-term vulnerability in Redcare Pharmacy. Fundamentals show negative EPS -1.87, a negative PE, and leverage pressure, while technical indicators signal oversold conditions. Our Meyka AI grade of 71.40 (B+, BUY) balances these risks with longer-term upside potential. Importantly, Meyka AI’s forecast model projects a yearly level of €94.27, implying +170.36% upside from today’s price, but near-term monthly guidance sits at €28.50 (-18.29%). Traders should watch the €30.00 support, the upcoming 06 May 2026 earnings, and volume for a conviction change. These forecasts are model projections and not guarantees; we recommend combining them with company reports, sector trends, and position sizing rules when trading RDC.DE on XETRA in EUR
FAQs
Why did RDC.DE stock fall sharply today?
RDC.DE stock fell due to heavy selling, weak earnings metrics, and sector pressure. High intraday volume of 176,480.00 shares amplified the move, while technicals turned oversold. News flow and broader European market weakness also contributed.
What are the key support and resistance levels for RDC.DE stock?
Immediate support sits near €30.00, with a stronger monthly model level at €28.50. Resistance is the day open €37.10 and the 50-day average €59.38. Watch volume before trading a breakout.
How does Meyka AI view RDC.DE stock performance and forecast?
Meyka AI rates RDC.DE 71.40 (Grade B+, Suggestion BUY). The model projects €28.50 monthly and €94.27 yearly. Forecasts are projections, not guarantees, and should be used with other analysis.
When is the next earnings date that could move RDC.DE stock?
Redcare Pharmacy’s next earnings announcement is scheduled for 06 May 2026. Earnings and guidance will likely be the main near-term catalyst for RDC.DE stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)